Seattle, WA – iGenix today announced it has received CLIA approval for its first diagnostic assay created to run on the Illumina BeadXpress, a high-throughput genomic analysis platform manufactured by Illumina Inc. The pharmacogenomics assay certified was built as a “proof-of-principle” test for CLIA certification, and is one of several in the iGenix R&D pipeline. […]
Kuala Lumpur, Malaysia – Sengenics today announced the introduction of a new microarray based genetic diagnostics test into Asia. The microarray used for the test was designed by Oxford Gene Technology (OGT), UK in conjunction with Emory Genetics, USA. Microarrays are now recommended as the most effective method for diagnosing children’s disorders. This was published […]
ATLANTA – Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a comprehensive range of clinical research and diagnostic products at the annual conference of the American Association for Clinical Chemistry (AACC). From automated sample handling to innovative sample analysis and storage solutions, ThermoFisher provides an integrated approach to accelerating results […]
ATLANTA — Thermo Fisher Scientific Inc., the world leader in serving science, today announced validated applications for Thermo Scientific immunoassays on Ortho Clinical Diagnostics’ VITROS® Systems. There are seven new manufacturer validated applications (MVA) which include: CEDIA® Cyclosporine Plus (including separate applications for both low and high range), CEDIA® Tacrolimus and CEDIA® Mycophenolic Acid assays […]
ATLANTA — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Indiko, a fully automated, compact, random access chemistry analyzer which recently received US Food and Drug Administration (FDA) clearance. Indiko™ is an easy to use, cost-effective system designed for clinical chemistry and specialty testing. The company will […]
HOPKINTON, Mass. – Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that its new, innovative LabChip® Dx instrument has achieved CE IVD registration in Europe. The LabChip Dx, a novel instrument based on Caliper’s robust LabChip microfluidics technology, will now be marketed and sold in Europe with the CE IVD Mark under the European Directive […]
SUNNYVALE, Calif. – Cepheid (NASDAQ: CPHD) today hosted ‘Art Meets Innovation,’ an event teaming Cepheid and Paul Jr. Designs for the unveiling of Cepheid’s redesigned GeneXpert® family of systems at the 2011 American Association of Clinical Chemistry and Clinical Lab Expo in Atlanta, GA. The unveiling of the redesigned GeneXpert family also introduces the new […]
ATLANTA – Singapore-based medical device company, Clearbridge BioLoc, today unveiled the prototype of its flagship product, AssayQuest™. This is a fully-automated, portable analysis platform that can perform complex and cost effective point-of-care testing from a finger-prick blood sample. It potentially enables clinicians and healthcare workers to conduct professional, laboratory-quality tests at the point-of-care, receiving the […]
Atlanta – Waters Corporation (WAT:NYSE) today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®). Being displayed in Waters booth #3136 are these exciting new products. • MassTrak™ Online Solid Phase Extraction Analyzer providing automated sample clean-up, concentration, and extraction complemented […]
ATLANTA – Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®) in adult kidney and cardiac transplant patients from human whole blood samples […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
